Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
18.2M
-
Shares change
-
+5.46M
-
Total reported value, excl. options
-
$783M
-
Value change
-
+$231M
-
Put/Call ratio
-
0.6
-
Number of buys
-
79
-
Number of sells
-
-45
-
Price
-
$42.90
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q3 2020
155 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q3 2020.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.2M shares
of 27.1M outstanding shares and own 67.1% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (2.5M shares), HealthCor Management, L.P. (1.59M shares), STATE STREET CORP (1.56M shares), FEDERATED HERMES, INC. (1.38M shares), BlackRock Inc. (1.16M shares), VANGUARD GROUP INC (1.04M shares), FMR LLC (770K shares), PRICE T ROWE ASSOCIATES INC /MD/ (703K shares), Cormorant Asset Management, LP (700K shares), and ORBIMED ADVISORS LLC (619K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.